Karnataka disclosed inspection findings on October 1 alleging large gaps between hospitals' medicine procurement costs and the prices charged to patients. The Indian Express reported Health Minister U. T. Khader's briefing, while ANI identified an October 1 Food Safety and Drug Administration press note. The findings include medicines used in cancer treatment and hospital consumables.
The state says institutions receive substantial purchasing discounts but patients may still pay prices close to the printed maximum retail price. It has asked the Centre for clearer bills showing procurement cost and MRP, wider price controls and regulation of trade margins. Khader's letter seeking central action was dated September 23, rather than October 1.
ANI reported that a September 25–26 verification drive covered more than 768 consumable items and 189 high-cost drugs. Further checks are planned. These are the administration's reported findings; they do not by themselves establish a legal violation by every hospital.
Separately, ETHealthworld reported the Association of Healthcare Providers of India's October 1 argument against a uniform medicine margin. The association cited storage, handling and clinical-service costs. Its statement addresses the wider pricing debate, rather than specifically rebutting Karnataka's inspection evidence.
The disclosure adds evidence to that debate. It does not mean the requested national billing and pricing changes are already in force.